Your browser doesn't support javascript.
loading
Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study.
Hwangbo, Yul; Kim, Jung Min; Park, Young Joo; Lee, Eun Kyung; Lee, You Jin; Park, Do Joon; Choi, Young Sik; Lee, Kang Dae; Sohn, Seo Young; Kim, Sun Wook; Chung, Jae Hoon; Lim, Dong Jun; Kim, Min Hee; Kim, Min Joo; Jo, Young Suk; Shong, Min Ho; Koong, Sung-Soo; Hahm, Jong Ryeal; Jung, Jung Hwa; Yi, Ka Hee.
Afiliação
  • Hwangbo Y; Center for Thyroid Cancer, National Cancer Center, Goyang 10408, Republic of Korea.
  • Kim JM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Park YJ; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul 01812, Republic of Korea; Departments of.
  • Lee EK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Lee YJ; Center for Thyroid Cancer, National Cancer Center, Goyang 10408, Republic of Korea.
  • Park DJ; Center for Thyroid Cancer, National Cancer Center, Goyang 10408, Republic of Korea.
  • Choi YS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Lee KD; Internal Medicine and.
  • Sohn SY; Otolaryngology-Head and Neck Surgery, Kosin University College of Medicine, Busan 49267, Republic of Korea.
  • Kim SW; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
  • Chung JH; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
  • Lim DJ; Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
  • Kim MH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea.
  • Kim MJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea.
  • Jo YS; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul 01812, Republic of Korea; Departments of.
  • Shong MH; Department of Internal Medicine, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.
  • Koong SS; Department of Internal Medicine, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.
  • Hahm JR; Department of Internal Medicine, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.
  • Jung JH; Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju 52727, Republic of Korea; and.
  • Yi KH; Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju 52727, Republic of Korea; and.
J Clin Endocrinol Metab ; 102(2): 625-633, 2017 02 01.
Article em En | MEDLINE | ID: mdl-27732329
Context: Small papillary thyroid cancer (PTC) generally has an excellent prognosis. However, long-term recurrence is not uncommon and sometimes leads to morbidity or mortality. Objective: To identify high-risk factors for long-term recurrence in patients with small PTC by stratifying their pathologic characteristics. Design, Setting, and Patients: We conducted a nationwide, retrospective, multicenter study of 3282 patients with PTC sized ≤2 cm from 9 high-volume hospitals in Korea. Main Outcome Measures: The maximally selected χ2 method was used to find the best cutoff points of tumor size, the number of metastatic lymph nodes (LNs), and the ratio of metastatic/examined LNs (LNR) to predict recurrence. Kaplan-Meier analysis and the Cox proportional hazards regression model were used to analyze recurrence and risk factors. Results: The optimal tumor size cutoff was 1.8 cm (10-year recurrence rates for tumors sized 0.1 to 1.7 cm and 1.8 to 2.0 cm: 7.7% vs 17.2%, respectively). Metastatic LNs ≤1 and ≥2 provided optimal estimates of recurrence (10-year recurrence rates: 4.0% vs 16.8%, respectively). The LNR of 0.19 was the optimal cutoff point for predicting the risk of recurrence (10-year recurrence rates for LNRs of 0 to 0.18 and 0.19 to 1: 2.7% vs 16.2%, respectively). LN metastasis, lobectomy, tumor size ≥1.8 cm, and bilateral tumors were independent risk factors for recurrence. Conclusions: Long-term recurrence was increased in patients who underwent lobectomy or with tumor sized ≥1.8 cm, 2 or more metastatic LNs, or bilateral tumors. For patients with these high-risk features, total thyroidectomy could be considered to avoid reoperation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Tireoidectomia / Neoplasias da Glândula Tireoide / Carcinoma / Medição de Risco / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Tireoidectomia / Neoplasias da Glândula Tireoide / Carcinoma / Medição de Risco / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2017 Tipo de documento: Article